• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

American Kidney Fund Taps AI Partner to Speed Early Diagnosis of Kidney Diseases

by Fred Pennic 07/22/2024 Leave a Comment

American Kidney Fund Taps AI Partner to Speed Early Diagnosis of Kidney Diseases

What You Should Know:  - Ubie, a global healthcare AI platform, and the American Kidney Fund (AKF), a leading kidney disease non-profit, have joined forces to improve early detection of kidney disease.  - This strategic collaboration aims to leverage Ubie's AI-powered Symptom Checker and AKF's expertise to empower patients and accelerate diagnosis. Why Early Diagnosis Matters Kidney disease is a major health concern, affecting millions in the US. Chronic kidney disease
Read More

Commure to Acquire Augmedix in $139M All-Cash Deal

by Fred Pennic 07/19/2024 Leave a Comment

Augmedix Expands AI Medical Documentation to Behavioral Health Market

What You Should Know:  - Augmedix (AUGX), a leader in AI-powered medical documentation and data solutions, is being acquired by healthcare technology provider Commure in an all-cash deal valued at approximately $139M. News of the acquisition brought Augmedix up by 150% at $2.27 at 10 am ET after closing at $0.92 on Thursday.  - Augmedix leverages AI technology to streamline medical documentation and data management for healthcare providers. Their platform uses ambient AI to
Read More

PCR is the Gold Standard of Testing. How Can It Be Improved?

by Jinyong Lee, CEO & Co-Founder of Kryptos Biotechnologies 07/19/2024 Leave a Comment

PCR is the Gold Standard of Testing. How Can It Be Improved?

Most of us have been tested for COVID-19 over the past few years. If that’s true of you, you know the routine: you go to a testing site, give your sample, a medical professional sends it to a laboratory, and you receive your results in a day or two. If this sounds familiar, you’ve benefited from PCR (Polymerase Chain Reaction) testing.  PCR is well known for its accuracy. It has limitations, however: it’s costly, time-consuming, and requires samples to be sent to central laboratories.
Read More

GE HealthCare Acquires Intelligent Ultrasound for $51M

by Fred Pennic 07/19/2024 Leave a Comment

GE HealthCare Acquires Intelligent Ultrasound for $51M

What You Should Know:  GE HealthCare (Nasdaq: GEHC) announced an agreement to acquire the clinical artificial intelligence (AI) software business of Intelligent Ultrasound Group PLC (Intelligent Ultrasound) for approximately $51M.  - The acquisition is expected to close in the fourth quarter of 2024, subject to customary closing conditions. GE HealthCare will finance the deal with existing cash reserves. The strategic acquisition signifies GE HealthCare's dedication to advancing
Read More

AI-Powered Deepfakes Fuel Surge in Social Media Supplement Scams

by Fred Pennic 07/19/2024 Leave a Comment

Deepfakes Fuel Surge in Social Media Supplement Scams

What You Should Know:  - Social media has become a breeding ground for deceptive health supplement ads, with AI-powered deepfakes taking these scams to a whole new level of danger. A recent study by Bitdefender Labs reveals a dramatic increase in phony social media ads promoting fictitious supplements and treatments.   -Researchers at Bitdefender Labs analyzed health-related scams on social media platforms like Facebook, Messenger, and Instagram over a three-month period,
Read More

Q Bio Secures $27M to Expand Full-Body MRI with Mark I Scanner

by Fred Pennic 07/18/2024 Leave a Comment

Q Bio Secures $27M to Expand Full-Body MRI with Mark I Scanner

What You Should Know:  - Q Bio Inc., a pioneer in medical imaging technology secures $27M in strategic funding to propel its innovative Mark I full-body scanner towards market launch. This investment round welcomes new investor TELUS Global Ventures alongside existing backers like Khosla Ventures, Andreessen Horowitz, Founders Fund, and Kaiser Foundation Hospitals. - Founded in 2015 by Jeff Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, Q Bio is dedicated to revolutionizing medical
Read More

Thoughtful AI Secures $20M, Launches Human-Capable RCM AI Agents

by Fred Pennic 07/18/2024 Leave a Comment

Thoughtful AI Secures $20M, Launches Human-Capable RCM AI Agents

What You Should Know:  - Thoughtful AI, a provider of AI-powered revenue cycle automation (RCM), has announced a series of exciting developments, including the launch of the world's first fully human-capable AI Agents for healthcare RCM, exceptional growth metrics, and $20 million in Series A funding. - Thoughtful AI's groundbreaking AI Agents, CAM, EVA, and PHIL, are tackling the burden of repetitive RCM tasks like claims processing, patient eligibility verification, and payment
Read More

Inaccurate Provider Directories: A Major Headache for Patients and Policymakers, HiLabs’ AI Study Reveals

by Fred Pennic 07/18/2024 Leave a Comment

Inaccurate Provider Directories: A Major Headache for Patients and Policymakers, HiLabs' AI Study Reveals

What You Should Know:  - Incorrect data in health plan physician directories is a pervasive problem, according to new research conducted by researchers at University of Colorado and HiLabs.  - The study, published in BMC Health Services Research, leverages HiLabs AI algorithms to compare data for >40% of US physicians across five large health plan directories. Key Findings: Limited variation in data quality between insurers suggests the issue goes beyond individual
Read More

Thyme Care Secures $95M to Expand Value-Based Cancer Care Platform

by Fred Pennic 07/17/2024 Leave a Comment

Thyme Care Launches Virtual Palliative Care Program to Enhance Cancer Care

What You Should Know:  - Thyme Care, a leading value-based cancer care enabler raises $95M in funding capital led by Concord Health Partners, with participation from existing investors including CVS Health® Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Foresite Capital, and new investor SignalFire. The funding brings Thyme Care's total funding to $178M. - Thyme Care is a value-based cancer care enabler focused on improving patient outcomes and
Read More

Freshpaint Raises $30.7M to Expand Healthcare Privacy Platform

by Jasmine Pennic 07/17/2024 Leave a Comment

Freshpaint Raises $30.7M to Expand Healthcare Privacy Platform

What You Should Know:  - Freshpaint, a San Francisco-based Healthcare Privacy Platform raises $30.7M in Series B funding led by Threshold, with participation from SignalFire, Intel Capital, Y Combinator, Zero Prime, and additional investors. This brings Freshpaint’s total funding to $41.8M. - Freshpaint is transforming how healthcare organizations approach marketing by enabling them to leverage the full potential of digital advertising tools while strictly adhering to privacy
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 112
  • Go to page 113
  • Go to page 114
  • Go to page 115
  • Go to page 116
  • Interim pages omitted …
  • Go to page 730
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |